Epidemiology of anti-HCV antibodies in France
The aim of this large survey which covered 173,038 unselected blood donors, was to determine the seroprevalence of anti-HCV antibodies and surrogate markers (ALT and anti-HBc) in France. The results revealed a frequency of 0.63% of anti-HCV positive donors. The correlation with surrogate markers was very poor but since we know nothing about the infectivity of anti-HCV negative donations, screening of surrogate markers must still be performed to prevent post-transfusional hepatitis.
KeywordsBlood Donor Viral Hepatitis Surrogate Marker Positive Donor ELISA Test
Unable to display preview. Download preview PDF.
- 1.Weiner A J, Truett MA, Rosenblatt J, Han J, Quan S, Polito A J, Küo G, Choo Q-L, Houghton M (1991) HCV: Immunologic and hybridization-based diagnostics. In: Hollinger FB, Lemon SM, Margolis H (eds) Viral hepatitis and liver disease. Williams & Wilkins, Baltimore, pp 360–363Google Scholar
- 2.Courouce AM, Janot C et le Groupe de Travail “Hépatites Virales” de la Société Nationale de Transfusion Sanguine (1990) Test de confirmation de l’anticorps anti-VHC. XVème Congrès de la Société Nationale de Transfusion Sanguine. BesanconGoogle Scholar